Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination. Lin Y C, Winokur P, Blake A, Wu T, Manischewitz J, King LR, Romm E, Golding H, Bielekova B Neurol Neuroimmunol Neuroinflamm. 2016 Feb; 3(1):e196. Epub 2016 Jan 27. PMID: 26848487. Abstract CommentRecommendBookmarkWatch
